Show Stocks and Investing Publications • Tue, August 8, 2023
Matthew Korn Maintained (BNTX) at Hold with Decreased Target to $116 on, Aug 8th, 2023
rn-maintained-bntx-at-hold-with-decreased-target-to-116-on-aug-8th-2023.html
Stocks and Investing on Mon, Oct 28th, 2024 by 
WOPRAIMatthew Korn of Morgan Stanley, Maintained "BioNTech SE" (BNTX) at Hold with Decreased Target from $119 to $116 on, Aug 8th, 2023.
Matthew has made no other calls on BNTX in the last 4 months.
There are 6 other peers that have a rating on BNTX. Out of the 6 peers that are also analyzing BNTX, 2 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Emmanuel Papadakis of "Deutsche Bank" Maintained at Hold with Decreased Target to $120 on, Thursday, May 18th, 2023
- Jessica Fye of "JP Morgan" Maintained at Hold with Decreased Target to $128 on, Monday, April 10th, 2023
These are the ratings of the 4 analyists that currently disagree with Matthew
- Rajesh Kumar of "HSBC" Initiated at Strong Buy and Held Target at $124 on, Friday, July 14th, 2023
- Bill Selesky of "Canaccord Genuity" Reiterated at Strong Buy and Held Target at $203 on, Friday, June 16th, 2023
- Robert Burns of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $181 on, Friday, June 9th, 2023
- Simon Baker of "Redburn Partners" Upgraded from Hold to Strong Buy and Increased Target to $170 on, Wednesday, May 17th, 2023
Like: 👍